CLINICAL PHARMACOKINETICS OF ETOPOSIDE DURING 120 HOURS CONTINUOUS INFUSIONS IN SOLID TUMORS

被引：32

作者：

DESOIZE, B ^{[1
]}

MARECHAL, F ^{[1
]}

CATTAN, A ^{[1
]}

机构：

[1] FAC PHARM REIMS,GIBSA,F-51100 REIMS,FRANCE

来源：

BRITISH JOURNAL OF CANCER | 1990年 / 62卷 / 05期

关键词：

D O I：

10.1038/bjc.1990.390

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：840 / 841

页数：2

共 10 条

[1] THE CLINICAL-PHARMACOLOGY OF ETOPOSIDE AND TENIPOSIDE [J].

CLARK, PI ;

SLEVIN, ML .

CLINICAL PHARMACOKINETICS, 1987, 12 (04) :223-252

[2]

CUNNINGHAM D, 1986, MED ONCOL TUMOR PHAR, V3, P95

[3] SUPERIORITY OF PERFUSION OVER BOLUS ADMINISTRATION IN CANCER-CHEMOTHERAPY - PROPOSITION OF A COMPARTMENTAL MODEL [J].

DESOIZE, B ;

GARRETT, ER .

MEDICAL HYPOTHESES, 1989, 29 (01) :21-24

[4]

DINCALCI M, 1986, CANCER RES, V46, P2566

[5] A PROSPECTIVE RANDOMIZED COMPARISON OF CONTINUOUS INFUSION FLUOROURACIL WITH A CONVENTIONAL BOLUS SCHEDULE IN METASTATIC COLORECTAL-CARCINOMA - A MID-ATLANTIC ONCOLOGY PROGRAM STUDY [J].

LOKICH, JJ ;

AHLGREN, JD ;

GULLO, JJ ;

PHILIPS, JA ;

FRYER, JG .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :425-432

[6]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[7]

2-6

[8]

POWIS G, 1985, CANCER CHEMOTH PHARM, V14, P177

[9] ADAPTIVE-CONTROL OF ETOPOSIDE ADMINISTRATION - IMPACT OF INTERPATIENT PHARMACODYNAMIC VARIABILITY [J].

RATAIN, MJ ;

SCHILSKY, RL ;

CHOI, KE ;

GUARNIERI, C ;

GRIMMER, D ;

VOGELZANG, NJ ;

SENEKJIAN, E ;

LIEBNER, MA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (03) :226-233

[10] CLINICAL PHARMACODYNAMICS OF CONTINUOUS INFUSION TENIPOSIDE - SYSTEMIC EXPOSURE AS A DETERMINANT OF RESPONSE IN A PHASE-I TRIAL [J].

RODMAN, JH ;

ABROMOWITCH, M ;

SINKULE, JA ;

HAYES, FA ;

RIVERA, GK ;

EVANS, WE .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (07) :1007-1014

← 1 →